Literature DB >> 32864596

Prediction of lung cancer risk at follow-up screening with low-dose CT: a training and validation study of a deep learning method.

Peng Huang1,2,3, Cheng T Lin4,3, Yuliang Li5, Martin C Tammemagi6, Malcolm V Brock7, Sukhinder Atkar-Khattra8, Yanxun Xu5, Ping Hu9, John R Mayo10, Heidi Schmidt11, Michel Gingras12, Sergio Pasian12, Lori Stewart13, Scott Tsai13, Jean M Seely14, Daria Manos15, Paul Burrowes16, Rick Bhatia17, Ming-Sound Tsao11, Stephen Lam18.   

Abstract

Background: Current lung cancer screening guidelines use mean diameter, volume or density of the largest lung nodule in the prior computed tomography (CT) or appearance of new nodule to determine the timing of the next CT. We aimed at developing a more accurate screening protocol by estimating the 3-year lung cancer risk after two screening CTs using deep machine learning (ML) of radiologist CT reading and other universally available clinical information.
Methods: A deep machine learning (ML) algorithm was developed from 25,097 participants who had received at least two CT screenings up to two years apart in the National Lung Screening Trial. Double-blinded validation was performed using 2,294 participants from the Pan-Canadian Early Detection of Lung Cancer Study (PanCan). Performance of ML score to inform lung cancer incidence was compared with Lung-RADS and volume doubling time using time-dependent ROC analysis. Exploratory analysis was performed to identify individuals with aggressive cancers and higher mortality rates. Findings: In the PanCan validation cohort, ML showed excellent discrimination with a 1-, 2- and 3-year time-dependent AUC values for cancer diagnosis of 0·968±0·013, 0·946±0·013 and 0·899±0·017. Although high ML score cohort included only 10% of the PanCan sample, it identified 94%, 85%, and 71% of incident and interval lung cancers diagnosed within 1, 2, and 3 years, respectively, after the second screening CT. Furthermore, individuals with high ML score had significantly higher mortality rates (HR=16·07, p<0·001) compared to those with lower risk. Interpretation: ML tool that recognizes patterns in both temporal and spatial changes as well as synergy among changes in nodule and non-nodule features may be used to accurately guide clinical management after the next scheduled repeat screening CT.

Entities:  

Keywords:  Lung cancer; Lung-RADS; deep machine learning; ensemble learning; screening; survival analysis; time-dependent ROC; volume doubling time

Mesh:

Year:  2019        PMID: 32864596      PMCID: PMC7450858          DOI: 10.1016/S2589-7500(19)30159-1

Source DB:  PubMed          Journal:  Lancet Digit Health        ISSN: 2589-7500


  25 in total

1.  Time-dependent ROC curves for censored survival data and a diagnostic marker.

Authors:  P J Heagerty; T Lumley; M S Pepe
Journal:  Biometrics       Date:  2000-06       Impact factor: 2.571

2.  British Thoracic Society guidelines for the investigation and management of pulmonary nodules.

Authors:  M E J Callister; D R Baldwin; A R Akram; S Barnard; P Cane; J Draffan; K Franks; F Gleeson; R Graham; P Malhotra; M Prokop; K Rodger; M Subesinghe; D Waller; I Woolhouse
Journal:  Thorax       Date:  2015-08       Impact factor: 9.139

Review 3.  A survey on deep learning in medical image analysis.

Authors:  Geert Litjens; Thijs Kooi; Babak Ehteshami Bejnordi; Arnaud Arindra Adiyoso Setio; Francesco Ciompi; Mohsen Ghafoorian; Jeroen A W M van der Laak; Bram van Ginneken; Clara I Sánchez
Journal:  Med Image Anal       Date:  2017-07-26       Impact factor: 8.545

4.  A neural network model for survival data.

Authors:  D Faraggi; R Simon
Journal:  Stat Med       Date:  1995-01-15       Impact factor: 2.373

5.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

6.  Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage.

Authors:  Balaji Ganeshan; Sandra Abaleke; Rupert C D Young; Christopher R Chatwin; Kenneth A Miles
Journal:  Cancer Imaging       Date:  2010-07-06       Impact factor: 3.909

7.  Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.

Authors:  Martin C Tammemagi; Heidi Schmidt; Simon Martel; Annette McWilliams; John R Goffin; Michael R Johnston; Garth Nicholas; Alain Tremblay; Rick Bhatia; Geoffrey Liu; Kam Soghrati; Kazuhiro Yasufuku; David M Hwang; Francis Laberge; Michel Gingras; Sergio Pasian; Christian Couture; John R Mayo; Paola V Nasute Fauerbach; Sukhinder Atkar-Khattra; Stuart J Peacock; Sonya Cressman; Diana Ionescu; John C English; Richard J Finley; John Yee; Serge Puksa; Lori Stewart; Scott Tsai; Ehsan Haider; Colm Boylan; Jean-Claude Cutz; Daria Manos; Zhaolin Xu; Glenwood D Goss; Jean M Seely; Kayvan Amjadi; Harmanjatinder S Sekhon; Paul Burrowes; Paul MacEachern; Stefan Urbanski; Don D Sin; Wan C Tan; Natasha B Leighl; Frances A Shepherd; William K Evans; Ming-Sound Tsao; Stephen Lam
Journal:  Lancet Oncol       Date:  2017-10-18       Impact factor: 41.316

8.  End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography.

Authors:  Diego Ardila; Atilla P Kiraly; Sujeeth Bharadwaj; Bokyung Choi; Joshua J Reicher; Lily Peng; Daniel Tse; Mozziyar Etemadi; Wenxing Ye; Greg Corrado; David P Naidich; Shravya Shetty
Journal:  Nat Med       Date:  2019-05-20       Impact factor: 53.440

9.  Towards automatic pulmonary nodule management in lung cancer screening with deep learning.

Authors:  Francesco Ciompi; Kaman Chung; Sarah J van Riel; Arnaud Arindra Adiyoso Setio; Paul K Gerke; Colin Jacobs; Ernst Th Scholten; Cornelia Schaefer-Prokop; Mathilde M W Wille; Alfonso Marchianò; Ugo Pastorino; Mathias Prokop; Bram van Ginneken
Journal:  Sci Rep       Date:  2017-04-19       Impact factor: 4.379

10.  Delta radiomic features improve prediction for lung cancer incidence: A nested case-control analysis of the National Lung Screening Trial.

Authors:  Dmitry Cherezov; Samuel H Hawkins; Dmitry B Goldgof; Lawrence O Hall; Ying Liu; Qian Li; Yoganand Balagurunathan; Robert J Gillies; Matthew B Schabath
Journal:  Cancer Med       Date:  2018-12-01       Impact factor: 4.452

View more
  18 in total

1.  Machine Learning in Oncology: Methods, Applications, and Challenges.

Authors:  Dimitris Bertsimas; Holly Wiberg
Journal:  JCO Clin Cancer Inform       Date:  2020-10

Review 2.  Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives.

Authors:  Matthijs Oudkerk; ShiYuan Liu; Marjolein A Heuvelmans; Joan E Walter; John K Field
Journal:  Nat Rev Clin Oncol       Date:  2020-10-12       Impact factor: 66.675

3.  Cancer Risk Estimation Combining Lung Screening CT with Clinical Data Elements.

Authors:  Riqiang Gao; Yucheng Tang; Mirza S Khan; Kaiwen Xu; Alexis B Paulson; Shelbi Sullivan; Yuankai Huo; Stephen Deppen; Pierre P Massion; Kim L Sandler; Bennett A Landman
Journal:  Radiol Artif Intell       Date:  2021-10-13

4.  Deep Learning for Lung Cancer Detection on Screening CT Scans: Results of a Large-Scale Public Competition and an Observer Study with 11 Radiologists.

Authors:  Colin Jacobs; Arnaud A A Setio; Ernst T Scholten; Paul K Gerke; Haimasree Bhattacharya; Firdaus A M Hoesein; Monique Brink; Erik Ranschaert; Pim A de Jong; Mario Silva; Bram Geurts; Kaman Chung; Steven Schalekamp; Joke Meersschaert; Anand Devaraj; Paul F Pinsky; Stephen C Lam; Bram van Ginneken; Keyvan Farahani
Journal:  Radiol Artif Intell       Date:  2021-10-27

Review 5.  A narrative review of deep learning applications in lung cancer research: from screening to prognostication.

Authors:  Jong Hyuk Lee; Eui Jin Hwang; Hyungjin Kim; Chang Min Park
Journal:  Transl Lung Cancer Res       Date:  2022-06

Review 6.  Artificial intelligence and imaging for risk prediction of pancreatic cancer: a narrative review.

Authors:  Touseef Ahmad Qureshi; Sehrish Javed; Tabasom Sarmadi; Stephen Jacob Pandol; Debiao Li
Journal:  Chin Clin Oncol       Date:  2022-02-09

7.  Solitary pulmonary nodule imaging approaches and the role of optical fibre-based technologies.

Authors:  Susan Fernandes; Gareth Williams; Elvira Williams; Katjana Ehrlich; James Stone; Neil Finlayson; Mark Bradley; Robert R Thomson; Ahsan R Akram; Kevin Dhaliwal
Journal:  Eur Respir J       Date:  2021-03-25       Impact factor: 16.671

Review 8.  AI in health and medicine.

Authors:  Pranav Rajpurkar; Emma Chen; Oishi Banerjee; Eric J Topol
Journal:  Nat Med       Date:  2022-01-20       Impact factor: 87.241

9.  Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary Nodules.

Authors:  Pierre P Massion; Sanja Antic; Sarim Ather; Carlos Arteta; Jan Brabec; Heidi Chen; Jerome Declerck; David Dufek; William Hickes; Timor Kadir; Jonas Kunst; Bennett A Landman; Reginald F Munden; Petr Novotny; Heiko Peschl; Lyndsey C Pickup; Catarina Santos; Gary T Smith; Ambika Talwar; Fergus Gleeson
Journal:  Am J Respir Crit Care Med       Date:  2020-07-15       Impact factor: 21.405

Review 10.  Noninvasive biomarkers for lung cancer diagnosis, where do we stand?

Authors:  Michael N Kammer; Pierre P Massion
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 3.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.